Last year in particular, pharmacists played a greater role in patient care with an increased workload as they connected patients, providers, and payers.
Eculizumab (Soliris; Alexion), a C5 inhibitor preventing cleavage into C5a and C5b, is widely considered the first-line therapy for high-risk TA-TMA.
Experts provide practice pearls for educating patients on and using FMTs for the management of CDI.
SMOs offer a range of services, including site selection, patient recruitment, data management, regulatory compliance, and quality assurance.
Nuances can lead to frequent areas of confusion.
Analyzing consolidation of 8 drug pump libraries into 1 IV infusion library in a 9-hospital system: from standardization to implementation.
This article discusses clinical data for noncovalent Bruton tyrosine kinase inhibitors (BTKis), novel strategies in CLL, and the practical management of BTKi toxicities.
A single-center experience at a tertiary medical center precision medicine clinic provides insight.
Studies show a need for coordination between the VA health care system and non-VA health care practices to decrease confusion and duplication of services.
Point-of-care testing can vary in complexity, but is always performed at or near a patient and at the site where care or treatment is provided.
Self-audits help onsite frontline pharmacy leaders and team members to assess compliance before an external surveyor enters their pharmacy to inspect medication use processes.
A diagnosis of Clostridioides difficile infection does not instantly require treatment, but new guidelines include recommendations for treatment when warranted.
Each therapy presents a different but effective treatment option.
Although the opioid epidemic is a broad societal problem, health systems can play a critical role in the response.
More cost effectiveness data is crucial in advocating for better insurance coverage in the United States.
Members, as well as health plans, pharmacy benefit managers, plan sponsors, and reinsurers want to know how to fund these expensive treatments to ensure positive outcomes.
Recognizing early signs and seeking medical care is essential for effective treatment and preventing long-term health complications.
By sharpening our vaccine confidence skills and advocating for expanded immunization scopes of practice, we can help improve convenient vaccine access in the US.
The use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.
SMOs offer a range of services, including site selection, patient recruitment, data management, regulatory compliance, and quality assurance.
Precision oncology represents an evolution in therapeutic practice.
Implementing these standards can be logistically challenging.
Data show these cases pose some of the most significant threats to patients and health systems.
With integrated specialty pharmacies enabling health systems to improve patient outcomes and lower total medical costs, every hospital will need a solution to support the growing number of patients on outpatient specialty medications.
Targeted therapies have greatly improved patient outcomes over the past 20 years.
One of the most important drivers of a patients’ uncontrolled hypertension is medication nonadherence.
It is the role of the pharmacist to ensure patients are adequately counseled on the adverse effects and potential harms of codeine.